In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Exiqon and Proligo to build global LNA business
Amersham Health and Link sign agreement
EXIQON TO ACQUIRE ONCOTECH INC AND ENTER THE MARKET FOR CANCER MOLECULAR DIAGNOSTICS IN 2008
Exiqon and Phoenix BioTechnologies sign license agreement
EXIQON FORMS COLLABORATION WITH RIGSHOSPITALET
EXIQON FORMS RESEARCH COLLABORATION WITH M. D. ANDERSON CANCER CENTER
Exiqon and IBA Gmbh announce license agreement on SALE of Locked Nucleic Acid (LNA™)
EXIQON LICENSES MICRORNA PCR TECHNOLOGY FROM ROSETTA INPHARMATICS